Carl L. Gordon - 08 Feb 2023 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role: Director, 10%+ Owner
Signature: /s/ Neil Lerner, attorney-in-fact
Issuer symbol: CMPX
Transactions as of: 08 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Feb 2023, 15:28:25 UTC
Previous filing: 28 Dec 2022
Next filing: 22 Feb 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMPX	Stock Option (Right to Buy)	Award	$0	+60,000		$0.000000	60,000	08 Feb 2023	Common Stock	60,000	$3.93	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest over 48 substantially equal monthly installments starting March 8, 2023.
F2	The Reporting Person is a member of OrbiMed Advisors LLC ("OrbiMed Advisors"). Pursuant to an agreement with OrbiMed Advisors, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors and OrbiMed Capital GP V LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V-KA, LP.

Content

The options vest over 48 substantially equal monthly installments starting March 8, 2023.

The Reporting Person is a member of OrbiMed Advisors LLC ("OrbiMed Advisors"). Pursuant to an agreement with OrbiMed Advisors, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors and OrbiMed Capital GP V LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V-KA, LP.